Who owns TSHA?
Institutional ownership of Taysha Gene Therapies Inc. from Form 13F, Q2 2026
209 institutional managers reported holding Taysha Gene Therapies Inc. (TSHA) in Form 13F filings for Q2 2026, with 299,592,871 shares worth $2.1B. The largest reported holder was Avoro Capital Advisors LLC. Managers that filed both quarters added a net 33,977,435 shares (+12.8%). 41 opened new positions and 22 sold out.
- Funds holding
- 209
- Value held
- $2.1B
- New / sold out
- 41 / 22
- Net shares, same filers
- +12.8%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of TSHA
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| Avoro Capital Advisors LLC | $163M | 8.0% | 23,888,888 | Added |
| Ra Capital Management, L.p. | $160M | 7.9% | 23,555,648 | Unchanged |
| Goldman Sachs Group Inc | $155M | 7.6% | 22,713,118 | Added |
| BlackRock, Inc. | $141M | 6.9% | 20,691,927 | Added |
| Vestal Point Capital, LP | $132M | 6.5% | 19,415,000 | Added |
| Morgan Stanley | $112M | 5.5% | 16,487,479 | Trimmed |
| RTW Investments, LP | $92.3M | 4.5% | 13,560,258 | Trimmed |
| FMR LLC | $90.8M | 4.5% | 13,336,413 | Trimmed |
| Vanguard Capital Management LLC | $85.0M | 4.2% | 12,478,595 | Added |
| State Street Corp | $77.8M | 3.8% | 11,421,920 | Added |
| Siren, L.L.C. | $67.1M | 3.3% | 9,846,579 | Added |
| Octagon Capital Advisors LP | $66.0M | 3.2% | 9,693,244 | Added |
| Geode Capital Management, LLC | $44.7M | 2.2% | 6,560,394 | Added |
| Polar Capital Holdings Plc | $34.8M | 1.7% | 5,117,133 | Trimmed |
| MPM Bioimpact LLC | $30.6M | 1.5% | 4,500,000 | New |
| D. E. Shaw & Co., Inc. | $30.0M | 1.5% | 4,398,652 | Trimmed |
| Baker Bros. Advisors LP | $27.3M | 1.3% | 4,004,756 | Unchanged |
| Wellington Management Group LLP | $27.1M | 1.3% | 3,975,605 | Added |
| Healthcare of Ontario Pension Plan Trust Fund | $26.5M | 1.3% | 3,885,501 | Added |
| GordonMD Global Investments LP | $24.5M | 0.2% | 723,185 | Trimmed |
| Casdin Capital, LLC | $22.1M | 1.1% | 3,250,000 | Unchanged |
| Vanguard Portfolio Management LLC | $21.4M | 1.0% | 3,140,009 | Added |
| ADAR1 Capital Management, LLC | $20.7M | 1.0% | 3,040,466 | Added |
| Pictet Asset Management Holding SA | $18.9M | 0.9% | 2,770,701 | Added |
| Aberdeen Group plc | $15.8M | 0.8% | 2,327,152 | Added |
Share of 13F holdings is each fund's shares as a share of the 299,592,871 TSHA shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- MPM Bioimpact LLC New+$30.6M
- Wellington Management Group LLP Added+$22.8M
- Pictet Asset Management Holding SA Added+$18.7M
- BlackRock, Inc. Added+$15.8M
- Farallon Capital Management, L.l.c. New+$15.3M
- Vanguard Capital Management LLC Added+$15.3M
- Norges Bank New+$15.2M
- Avoro Capital Advisors LLC Added+$14.9M
- Orbimed Advisors LLC New+$13.6M
- Heights Capital Management, Inc New+$10.2M
Biggest sellers in Q2 2026
- SG Americas Securities, LLC Trimmed-$13.4M
- Deerfield Management Company, L.p. Sold out-$12.2M
- Morgan Stanley Trimmed-$10.1M
- Barclays PLC Trimmed-$8.0M
- Millennium Management LLC Trimmed-$7.9M
- FMR LLC Trimmed-$6.7M
- Polar Capital Holdings Plc Trimmed-$3.7M
- Two Sigma Investments, LP Trimmed-$3.5M
- Bank of America Corp Trimmed-$2.1M
- Point72 Asset Management, L.P. Sold out-$2.1M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $323M and sold $82.4M; 99 added and 40 trimmed.
Schedule 13D and 13G filings on TSHA
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2025-07-03GOLDMAN SACHS GROUP INC SCHEDULE 13G filed by Taysha Gene Therapies Inc.Schedule 13G
- 2025-02-05MORGAN STANLEY SCHEDULE 13G filed by Taysha Gene Therapies Inc.Schedule 13G
Questions about TSHA ownership
- Who owns TSHA stock?
- 209 institutional investment managers reported TSHA positions in their Form 13F filings for Q2 2026, holding 299,592,871 shares worth $2.1B in total. Avoro Capital Advisors LLC reported the largest position.
- Are funds buying or selling TSHA?
- In Q2 2026, 41 managers opened new TSHA positions, 99 added, 40 trimmed and 22 sold out. Managers that filed in both quarters added a net 33,977,435 shares.
- How current is this TSHA institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to TSHA by CUSIP. Options are left out. TSHA news and filings · TSHA insider trades · Top funds